Arkolith/Insider Trading/EW/Form 4

Zovighian Bernard J

CEO, DirectorEdwards Lifesciences Corp (EW) · full profile →Form 4 · filed May 11, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
7 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Gift(G)5K—$022K
May 11, 2026Gift(G)5K—$0105K
May 8, 2026Gift(G)4K—$016K
May 8, 2026Gift(G)4K—$0116K
May 8, 2026Tax withholding(F)5K$82.76$447K110K
May 7, 2026Grant(A)44K—$0124K
May 7, 2026Tax withholding(F)4K$83.20$346K120K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 7, 2026Grant(A)245K—$0245K
May 7, 2026Grant(A)44K—$044K

Transaction Codes

G
Gift
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-005131) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML